The DOI matches its Crossref record; 154 of the 158 references it cites were found in a registry or an index.
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
Open accessAbstract
Background: Diabetes mellitus and cancer are commonly coexisting illnesses, and the global incidence and prevalence of both are rising. Cancer patients with diabetes face unique challenges. This review highlights the relationship between diabetes and cancer and various aspects of the management of diabetes in cancer patients. Methods: A literature search using keywords in PubMed was performed. Studies that were published in English prior to July 2021 were assessed and an overview of epidemiology, cancer risk, outcomes, treatment-related hyperglycemia and management of diabetes in cancer patients is provided. Results: Overall, 8–18% of cancer patients have diabetes as a comorbid medical condition. Diabetes is a risk factor for certain solid malignancies, such as pancreatic, liver, colon, breast, and endometrial cancer. Several novel targeted compounds and immunotherapies can cause hyperglycemia. Nevertheless, most patients undergoing cancer therapy can be managed with an appropriate glucose lowering agent without the need for discontinuation of cancer treatment. Evidence suggests that cancer patients with diabetes have higher cancer-related mortality; therefore, a multidisciplinary approach is important in the management of patients with diabetes and cancer for a better outcome. Conclusions: Future studies are required to better understand the underlying mechanism between the risk of cancer and diabetes. Furthermore, high-quality prospective studies evaluating management of diabetes in cancer patients using innovative tools are needed. A patient-centered approach is important in cancer patients with diabetes to avoid adverse outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Likewise, interindividual variability in baseline management, comorbidities, insulin sensitivity, and mode of insulin delivery (MDI, AID, or HCL/AHCL) contribute to the wide range of adjustments reported.”
From A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies (2026) · cites this paper as [62]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622
Rinke, A., Müller, H., Schade‐Brittinger, C., Klose, K., Barth, P. J., Wied, M., Mayer, C., Aminossadati, B., Pape, U., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,507
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Cited by
Sorted by citations
Items 101–187 of 187
Andersson, E., Brådvik, G., Nilsson, F. O. L., Arpegård, J., Strambi, A., Kollberg, P., & Carlsson, K. S. (2024) · BMC Urology · doi:10.1186/s12894-024-01536-2 · Cited by 2
Influence of diabetes on microbiome in prostate tissues of patients with prostate cancer
Lee, J.-J., Kim, J. K., Oh, B., Hong, S. K., & Kim, B. S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1445375 · Cited by 2
Peng, Y., Wang, P., Liu, F., Wang, X., Si, C., Gong, J., Zhou, H., & Song, F. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038180 · Cited by 2
Julius, A., Malakondaiah, S., & Pothireddy, R. B. (2025) · Discover Medicine · doi:10.1007/s44337-025-00286-w · Cited by 2
Saravanan, K., Seenuvasakumaran, P., Baig, A. U., Sudha, P. N., Ayyanar, M., Sivakami, M., Balaji, R., Abarna, P., Jenipher, C., Ravichandran, K., et al. (2025) · Next Materials · doi:10.1016/j.nxmate.2025.100708 · Cited by 2
Poudyal, S., Rothe, F., Jeong, S., Gleim, N., Hambsch, P. K., Nägler, F., Papsdorf, K., Kuhnt, T., Barrantes‐Freer, A., Güresir, E., et al. (2025) · Strahlentherapie und Onkologie · doi:10.1007/s00066-025-02414-y · Cited by 2
Co-morbid diabetes mellitus in cancer patients undergoing treatment: a case series and perspective
Aisiri, H. U. V., Rao, M. R., Ramani, V. K., & Naik, R. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1615491 · Cited by 2
Dispositivi indossabili per la gestione del diabete
Carlucci, F., Tabucchi, A., Fiorini, M., Galasso, L., & Terreni, A. (2025) · Biochimica Clinica · doi:10.23736/s0393-0564.25.00067-6 · Cited by 2
Mohamed, G. A., Alqarni, A. A., Abdallah, H. M., Omar, A. M., & Ibrahim, S. R. M. (2023) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v22i4.12 · Cited by 2
Šiaulienė, L., Kazlauskaitė, J., Jurkėnaitė, D., Visockienė, Ž., & Lazutka, J. R. (2023) · Life · doi:10.3390/life13091926 · Cited by 2
Al‐Taie, A., Al-Rashid, A. A. D., & Rahim, N. S. B. A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01811-5 · Cited by 2
Wang, Y., Ding, Y., Yan, X., Yao, J., Wang, M., Li, Z., & Zhu, Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s550192 · Cited by 1
Andena, P., Tine, G., Nichetti, F., Pretta, A., Bartalini, L., Ljevar, S., Michelotti, A., Salvatore, L., Prisciandaro, M., Franza, A., et al. (2025) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2025.100276 · Cited by 1
The Importance of Understanding the Link Between Diabetes and Cancer
Kiruthiga, C., Das, M., Kamaladevi, A., & Kulanthaivel, L. (2026) · Springer eBooks · doi:10.1007/978-981-95-5651-9_6 · Cited by 1
Chen, Z., Wang, X. H., Zhang, Z., Lu, Y., Lei, C. Z., Di, Y., Huang, Y., & Li, Y. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1701515 · Cited by 1
Influence of diabetes on survival of patients with glioma: a meta-analysis
Yi, J., Wen, J., Wang, N., Yuan, M., Leng, H., & Chen, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1667242 · Cited by 1
Gui, S., Tang, R.-X., Huang, X., Yang, G.-Q., & Jing, Y. A. N. G. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v18.i2.113476 · Cited by 1
Reytor-González, C., Frias-Toral, E., Annunziata, G., Simancas‐Racines, D., & Barrea, L. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.03.002 · Cited by 1
Murfet, N., Mullan, L., Johansen, C., Livingston, P. M., WHITE, V. M., Rothmann, M. J., & Rasmussen, B. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103401 · Cited by 1
Apurva, Chaudhary, P., & Bahuguna, S. (2026) · Current Cancer Therapy Reviews · doi:10.2174/0115733947414188251210123952 · Cited by 1
Shahid, R. K., Brabant, M., Mondal, P., Ahmed, O., Manna, M., & Ahmed, S. (2026) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2026.05.005 · Cited by 1
Self-citationGlycation stress in glioma: a metabolic vulnerability and therapeutic target
Umdor, S. B., & Sen, E. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00904-z · Cited by 1
Cao, K., Wu, J. C., Hernandez, M., & Ganti, L. (2022) · Cureus · doi:10.7759/cureus.24491 · Cited by 1
Pancreatic cancer, pancreatogenic diabetes, type 2 diabetes mellitus
Друк, И. В. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-205-9-171-182 · Cited by 1
Metformin as an adjuvant option for systemic treatment of breast cancer
Avierin, D. I., & Завізіон, В. Ф. (2023) · Medicni perspektivi · doi:10.26641/2307-0404.2023.4.294154 · Cited by 1
Shouman, M., Jaffa, A. A., & Jaffa, M. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1562854 · Cited by 1
Acrocomia aculeata Oil-Loaded Nanoemulsion: A Promising Candidate for Cancer and Diabetes Management
Prada, A. L., Amado, J. R. R., Perdomo, R. T., Gomes, G. B., de Almeida, D. A. T., Cavalheiro, L. F., Gasparotto, A., Neto, S. F., & Martines, M. A. U. (2025) · Pharmaceuticals · doi:10.3390/ph18081094 · Cited by 1
Franco-Torres, D. A., Palacios-Flores, P., Avalos, A., & Sánchez-Barajas, M. (2025) · medRxiv · doi:10.1101/2025.06.14.25328942 · Cited by 1
Endocrine issues and premenopausal breast cancer – case report and review of literature
Carşote, M., RENTEA, D. E., Petca, A. T., ZUGRAVU, S., Mehedințu, C., Şandru, F., Dumitrascu, A. S., & DUMITRASCU, M. C. (2021) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2021.4.25
Impact of Diabetes on Clinical Outcomes of Prostate Cancer
Özçelik, M., Yaprak, G., Gemici, C., Oyman, A., Çil, I., & Özçelik, S. (2022) · Eurasian Journal of Medical Advances · doi:10.14744/ejma.2022.72792
García, C. E., & García‐Valverde, A. (2022) · Diabetes práctica · doi:10.52102/diabet/pract/2022.2/art2
Glucose metabolism disorders in cancer patients
Różycka, K., & Kapała, A. (2023) · Nowotwory Journal of Oncology · doi:10.5603/njo.a2023.0034
Lu, X.-P., Chen, A., Wu, M.-C., Tseng, H., & Kao, P. (2023) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004940
In Silico Analysis of the Potential of Mangifera Sumatrana as an Antidiabetic
Roza, R. M., & Roza, R. M. (2023) · Journal of Hunan University Natural Sciences · doi:10.55463/issn.1674-2974.50.10.4
Khushboo, I., Kumar, M., Hameed, S., Kumari, S., & Dikshit, H. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23905131123
G2A as a key modulator of carbonyl stress and apoptosis resistance in glucose-loaded cancer cells
Hassan, M. A., Fukui, T., Shimizu, H., & Kishimoto, K. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150516
Daniel, J. M. M., Mathiazhagan, G., & Sathick, I. J. (2024) · Springer eBooks · doi:10.1007/978-981-97-6406-8_18
Schubel, L., Barac, A., Magee, M. F., Méte, M., Peeples, M., Shomali, M. E., Miller, K., Bangerter, L. R., Fong, A., Gallagher, C., et al. (2024) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2024.101387 · Cited by 1
A review on diabetes and oral cancer: Molecular links and implications.
Jayaseelan, V. P., & Pandi, A. (2025) · PubMed Central · doi:10.22099/mbrc.2024.51225.2042
Zhang, Y. F., Chang, C.-P. E., Varghese, T. K., Tao, R., & Hashibe, M. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01786-5
Seth, K., Evaline, K., Bernard, G., & Swaya, T. O. (2025) · Research Square · doi:10.21203/rs.3.rs-5976587/v1
Jiang, M., Jiang, Y., Li, X., Duan, H., & Shi, J. (2025) · European Journal of Cancer Care · doi:10.1155/ecc/7742472
Vitruvian Health: the future of medicine and healthcare?
Franco, O. H. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108624
Luo, L., Knol, M., Kieneker, L. M., van der Vegt, B., Bakker, S. J. L., Gruppen, E. G., de Boer, R. A., Aboumsallem, J. P., Connelly, M. A., Dullaart, R. P. F., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70100
Effect of Sleeve Gastrectomy on Cancer Prevention
Lazzati, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-77690-8_57-1
Yao, M., Wang, R., Cui, R., Lou, F., & Chen, Z. (2025) · Discover Oncology · doi:10.1007/s12672-025-03476-1
Huang, J., Zhong, C. C., Li, Z., Jiang, Y., Yang, Z., Yuan, J., Poon, J. K., Dou, Q., & Wong, M. C. S. (2025) · Oncology · doi:10.1159/000548220
Fu, M., Peng, Z., Xue, Y., Lv, D., & Wu, M. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03189-z
Htike, K. M., Thi, W. M., & Kumar, R. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01768-5
Gorbatov, M. L., Rodriguez, C., Gorbatov, S. D., & Farias, A. J. (2025) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-025-02731-z
Lloyd-Davies, E., & Westfall, A. (2025) · Physician Assistant Clinics · doi:10.1016/j.cpha.2025.11.002
Andersson, E., Brådvik, G., Nilsson, F. O. L., Arpegård, J., Strambi, A., Kollberg, P., & Carlsson, K. S. (2024) · Figshare · doi:10.6084/m9.figshare.26322666
Pothuraju, R., Susmitha, A., Meriga, P. K., Bandi, P., Eri, G. K., & Dugasani, S. R. (2025) · Oriental Journal Of Chemistry · doi:10.13005/ojc/410602
Why Do Patients with Cancer Die? Insights from the COVID-19 Pandemic
Paul, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-08808-6_3
An Overview of Diabetes and Cancer Risks: Types and Mechanisms
Muruganantham, J. K., & Veerabathiran, R. (2026) · Springer eBooks · doi:10.1007/978-981-95-5651-9_1
Understanding the Connection Between Diabetes and Cancer
Sekar, P. K. C., & Veerabathiran, R. (2026) · Springer eBooks · doi:10.1007/978-981-95-5651-9_2
Strategies for Reducing the Risk of Diabetes and Cancer
Kamaladevi, A., Das, M., Kiruthiga, C., & Kulanthaivel, L. (2026) · Springer eBooks · doi:10.1007/978-981-95-5651-9_5
Bansal, S., Burman, A., Arora, T., Vachher, M., Wali, N. M., & Kumar, B. (2026) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2025.1752493
Cardiovascular Disease and Cancer: Two Sides of the Same Coin
Fusco, S. A. D., Canale, M. L., Oliva, S., Bisceglia, I., Gallucci, G., Spinelli, A., Alonzo, A., Concistrè, A., Fabiani, I., Donne, M. G. D., et al. (2026) · Cardiology · doi:10.1159/000550818
Tollosa, D. N., Juárez, S., Grotta, A., & Rostila, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-39293-x
Perelman, M. G., Brzezinski, R. Y., Banai, S., Wolf, I., & Laufer‐Perl, M. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.042404
Impact of diabetes mellitus in cancer
Hadrian Noel Alexander, F., Muzumder, S., Johnson, S. M., Srikantia, N., Udayashankara, A. H., & Jayalekshmi, R. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1911_2025
Guo, L., Liu, J., Gao, R., Yang, C., Li, Z., Guan, Z., Wang, Y., Liu, G., Ma, J. G., & Gao, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1776717
Panayotova, I. N., Hallare, M., & Savatorova, V. L. (2026) · Synthesis lectures on mathematics and statistics · doi:10.1007/978-3-032-17486-4_2
Khan, F., Javed, A. S., Ayyazuddin, M., & AHMAD, A. (2026) · Minerva Endocrinology · doi:10.23736/s2724-6507.26.04552-5
Yang, K., Thong, M. S. Y., Doege, D., Koch‐Gallenkamp, L., Weißer, L., Bertram, H., Eberle, A., Holleczek, B., Nennecke, A., Waldmann, A., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03463-5
Ismail, M., Gong, J., Marshall, V. D., Farris, K. B., & Mackler, E. R. (2026) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552261451729
Zafar, R., Pham, T. D., Vakafua, L., Reed, T., & Seyedasli, N. (2026) · Pharmaceuticals · doi:10.3390/ph19050769
Mortality trends in the co-occurrence of urinary tract cancer and diabetes mellitus
Ou, C., Xiong, Y., Meng, X.-D., Lv, T., & Song, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1843044
Alriyami, M., Malehi, A. S., Kamyani, A. A., Jabri, F. A., Alhosni, M., Saadi, K. A., Al-Maqbali, S., Al-Shuaili, T. K., & Al-Futaisi, A. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350276
Spencer, R., Jones, G., McHugh, S., Ajjan, R., Birch, R. J., & Ashley, L. (2026) · British Journal of Health Psychology · doi:10.1111/bjhp.70088
Diaminoguanidine based manganese(II) complex and its multifaceted bioactivity evaluation
Krishnapriya, M. J., Antharjanam, P. K. S., & Manoj, E. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.146914
Crockett, A., McCAUGHEY, C., Dornan, M., Donovan, M., & Aughey, E. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10947-w
Smith, C., Collins, S., Colombo, C., Declercq, D., Katz, T., Kalnins, D., Scheers, I., Peckham, D. G., Snowball, J., & Wilschanski, M. A. (2026) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2026.06.010
Elevated Fasting Glucose in Patients with Lymphoma: A Real-World Observational Study
Fehr, N., Walter, J. E., Bojanic, B., Sartoretti, T., Schwyzer, M., Binz, K., Gennari, A. G., Huellner, M. W., Messerli, M., & Ernst, M. (2026) · Diabetology · doi:10.3390/diabetology7070126
Zhu, X., Han, Y., Sun, Q., Zhu, M., Yan, C., Yu, C., Sun, D. J. Y., Pei, P., Jiang, Y., Chen, J., et al. (2026) · Engineering · doi:10.1016/j.eng.2026.07.009
Osafehinti, D. A., Thosani, S., & Weitzman, S. P. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261470745
Breast Cancer and Diabetes Mellitus: Epidemiology, Pathophysiology, and Clinical Outcomes
Saeed, H., Habib, R., Arnold, E., Ahmed, S., & Shahid, R. K. (2026) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2026.100143
Self-citationMunshi, M. N., Lee, A., Kerr, K. W., & Poon, Y. (2026) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702261489433
Repurposing metabolic drugs: Anti-diabetic and anti-obesity agents with potential in cancer therapy
Uti, D. E., Almohaimeed, H. M., Aggad, W. S., Egbung, J. E., Anthony, B. O., Ogar, R. O., & Alum, E. U. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100747
A USP28-BRD4 axis contributes to the acceleration of breast cancer growth by hyperglycemia
Li, N., Zhu, Z., Li, Z., Hu, Z., Li, X., Qian, K., Chen, Y., Huang, Y., Sun, L., & Song, T. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118033
Metadata
- Authors
- Shahid, R. K., Ahmed, S., Le, D., & Yadav, S.
- Affiliations
- University of Saskatchewan (CA)
- Corresponding author
- Ahmed, Shahid
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-11-16
- Volume
- 13
- Issue
- 22
- Pages
- 5735
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8616213
- OpenAlex
- W3213879794
- Cited by
- 187
- References
- 158
- Citations by year
- 2026: 44 · 2025: 54 · 2024: 41 · 2023: 34 · 2022: 13 · 2021: 1
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, cancer, comorbidities, cancer risk, glucose-lowering agents, cancer mortality, immune-related adverse events, targeted therapy, multidisciplinary management, pancreatic cancer, liver cancer, breast cancer, endometrial cancer, colon cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
